Butabindide is primarily utilized in biochemical research as a selective inhibitor of thimet oligopeptidase (TOP), an enzyme involved in peptide metabolism. Its application is significant in studies focusing on understanding the role of TOP in various physiological and pathological processes, including neuropeptide regulation and neurodegenerative diseases. Researchers use butabindide to explore its potential therapeutic effects in conditions such as Alzheimer's disease and other cognitive disorders. Additionally, it aids in investigating the enzyme's involvement in pain modulation and inflammation, providing insights for developing targeted treatments.